Navigation Links
Laser Therapy Switches Cocaine Addiction On, Off in Rats: Study

WEDNESDAY, April 3 (HealthDay News) -- Rats addicted to cocaine lost the craving when researchers used laser light to stimulate a specific part of their brains.

The same team of scientists also used the laser technique to trigger new cocaine addictions in rats. They say the therapy -- which targets the prefrontal cortex of the rat brain -- could point the way to a new method of treating the addiction in humans.

"When we turn on a laser light in the prelimbic region of the prefrontal cortex, the compulsive cocaine seeking is gone," study co-researcher Dr. Antonello Bonci, adjunct professor of neurology at the University of California, San Francisco, said in a university news release.

As the researchers explained, the mammalian prefrontal cortex plays an important role in impulse control, decision-making and behavioral flexibility.

In this study, the researchers used genetic engineering to insert light-sensitive proteins called rhodopsins into nerve cells (neurons) in the rats' prefrontal cortex. Activating this brain region with a laser tuned to the rhodopsins turned the neurons on and off.

Turning on the neurons eliminated cocaine addiction while turning them off triggered addiction in the rats, according to the study published online April 3 in the journal Nature.

The findings highlight the central role the prefrontal cortex plays in cocaine addiction and also suggest a new therapy that could be immediately tested in humans, said the team of researchers from UCSF and the U.S. National Institute of Drug Abuse (NIDA).

However, human therapy would not use lasers. Instead, it would most likely rely on electromagnetic stimulation outside the scalp -- in particular, a technique called transcranial magnetic stimulation (TMS) -- to trigger a similar activation in the prefrontal cortex. TMS has been used to treat depression.

Research in animals often does not pan out in humans, experts note. However, clinical trials are now being designed to test the use of TMS in people, said Bonci, who is also scientific director of the intramural research program at NIDA and an adjunct professor at Johns Hopkins University in Baltimore.

In the clinical trials, TMS will be used a few sessions a week to stimulate the prefrontal cortex in cocaine addicts. The researchers will see if they can restore activity to the prefrontal cortex and help reduce the addicts' desire for cocaine.

An estimated 1.4 million Americans are addicted to cocaine, which was the reason for more than 482,000 emergency department visits in 2008 and is a leading cause of heart attack and stroke among people younger than 35.

Along with the health toll, cocaine has a major impact on crime, imprisonment, treatment and prevention programs, lost job productivity and lost earnings, the researchers pointed out.

More information

The U.S. National Institute on Drug Abuse has more about cocaine.

-- Robert Preidt

SOURCE: University of California, San Francisco, news release, April 3, 2013

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Slicing mitotic spindle with lasers, nanosurgeons unravel old pole-to-pole theory
2. Screening for breast cancer without X-rays: Lasers and sound merge in promising diagnostic technique
3. Ultra-short laser pulses for science and industry
4. Higher energies for laser-accelerated particles possible
5. Laser treatment improves appearance in burn scars, study shows
6. Studies Show Limits, Promise of Laser Removal of Tattoos
7. Laser-light testing of breast tumor fiber patterns helps show whose cancer is spreading
8. Beachwood Hair Clinic Announces Laser Hair Removal Services
9. No more lying about your age: Scientists can now gauge skin’s true age with new laser technique
10. FDA Clears Laser for all Critical Steps in Cataract Surgery: Center For Sight Performs the Most LENSAR Laser Procedures in U.S.
11. Long Island Counsilman Inaugurates New Laser Center
Post Your Comments:
Related Image:
Laser Therapy Switches Cocaine Addiction On, Off in Rats: Study
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 27, 2015 , ... Keeping in mind challenges faced by ... wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for ... parents and bring advice from parenting experts within their reach. As a part ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... November 26, 2015 , ... The ... bioavailability and the need to integrate dose form selection in early phase drug ... the membership organization supporting and bringing together the UK’s emerging life sciences companies, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Health-E-minds ... collaborated with Women’s Web – an online resource for Indian women looking ... and emotional well-being relationship, life balance, stress, professional development, and lifestyle. Health-E-minds ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: